Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · IEX Real-Time Price · USD
2.350
-0.105 (-4.28%)
At close: Apr 30, 2024, 4:00 PM
2.460
+0.110 (4.68%)
After-hours: Apr 30, 2024, 5:34 PM EDT
Organogenesis Holdings Revenue
In the year 2023, Organogenesis Holdings had annual revenue of $433.14M, a decrease of -3.94%. Revenue in the quarter ending December 31, 2023 was $99.65M, a -13.73% decrease year-over-year.
Revenue (ttm)
$433.14M
Revenue Growth
-3.94%
P/S Ratio
0.72
Revenue / Employee
$502,483
Employees
862
Market Cap
310.11M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 433.14M | -17.75M | -3.94% |
| Dec 31, 2022 | 450.89M | -16.47M | -3.52% |
| Dec 31, 2021 | 467.36M | 129.06M | 38.15% |
| Dec 31, 2020 | 338.30M | 77.32M | 29.63% |
| Dec 31, 2019 | 260.98M | 67.53M | 34.91% |
| Dec 31, 2018 | 193.45M | -5.06M | -2.55% |
| Dec 31, 2017 | 198.51M | 59.78M | 43.09% |
| Dec 31, 2016 | 138.73M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AirSculpt Technologies | 195.92M |
| Cerus | 186.80M |
| Spok Holdings | 139.03M |
| SOPHiA GENETICS | 62.37M |
| CVRx, Inc. | 39.30M |
| Nyxoah | 4.83M |
| Immutep | 4.58M |
| Atai Life Sciences | 314.00K |
ORGO News
- 14 days ago - Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024 - GlobeNewsWire
- 27 days ago - Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case - GlobeNewsWire
- 2 months ago - Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance - GlobeNewsWire
- 2 months ago - Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference - GlobeNewsWire
- 2 months ago - Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024 - GlobeNewsWire
- 5 months ago - ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Business Wire
- 6 months ago - Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results - GlobeNewsWire
- 7 months ago - Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023 - GlobeNewsWire